業績｜論文・出版物｜目次｜ALL

miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells.

Sakai E., Imaizumi T., Suzuki R., Taracena-G?ndara M., Fujimoto T., Sakurai F., Mizuguchi H.

Communi. Biol., 6 (2023)

Label-free evaluation of maturation and hepatotoxicity of human iPSC-derived hepatocytes using hyperspectral Raman imaging.

Li M., Ueyama-Toba Y., Lindley M., Kongklad G., Nawa Y., Kumamoto Y., Ishida S., Kanda Y., Fujita S., Mizuguchi H., Fujita, K.

Anal. Chem., 95, 9252-9262 (2023)

PubMed

Treatment of human pancreatic cancers following local and systemic administration of oncolytic adenovirus serotype 35.

Ono R., Takayama K., Onishi R., Tokuoka S., Sakurai F., Mizuguchi H.

Anticancer Res., 43, 537-546 (2023)

PubMed

Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions.

Inui J., Ueyama-Toba Y., Mitani S., Mizuguchi H.

PLoS ONE, 18, e0285783 (2023)

WebSite

Regional transcriptomics and proteomics of pharmacokinetics-related genes in human intestine.

Murata M., Fujioka H., Yokota J., Okada K., Yamashita T., Hirayama D., Kawakami K., Morinaga G., Saito A., Nakase H., Kishimoto W., Mizuguchi H.

Mol. Pharm., 20, 2876-2890 (2023)

PubMed

Biliary epithelial cell differentiation of bipotent human liver-derived organoids by 2D and 3D culture.

Tong Y., Ueyama-Toba Y., Mizuguchi H.

Biochem. Biophys. Rep., 33, 101432 (2023)

PubMed

Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes.

Eguchi M., Hirata S., Ishigami I., Shuwari N., Ono R., Tachibana M., Tanuma M., Kasai A., Hashimoto H., Ogawara KI., Mizuguchi H., Sakurai F.

J. Cont. Rel., 354, 35-44 (2023)

PubMed

Establishment of MDR1-knockout human enteroids for pharmaceutical application

Inui T., Nomoto R., Yokota J., Yamashita T., Okada K., Kishimoto W., Nakase H., Mizuguchi H.

Drug Metab Pharmacokinet., 48, 100476 (2023)

PubMed

Comparison of human biopsy-derived and human iPS cell-derived intestinal organoids established from a single individual

Inui T., Yamashita T., Tomita J., Yokota J., Kishimoto W., Nakase H., Mizuguchi H.

Drug Metab Pharmacokinet., 48, 100482 (2023)

WebSite

Y-27632

植山（鳥羽）由希子、水口裕之

消化器病学サイエンス, 7, 162 (2023)

新規アデノウイルス製剤　～非増殖型ベクターと腫瘍溶解性ウイルス～

水口裕之

医学のあゆみ, 285, 310-316 (2023)

ヒトiPS細胞を用いた食の評価系　～ヒトiPS細胞から分化誘導した腸管上皮細胞～

水口裕之

実験医学, 41, 1584-1588 (2023)

腫瘍溶解性ウイルスによる抗腫瘍免疫の活性化とがん免疫療法との併用

櫻井文教、水口裕之

ドラッグデリバリーシステム, 38, 24-30 (2023)

アデノウイルスベクター

水口裕之

遺伝子細胞治療ハンドブック, 2, 30-36 (2023)

幹細胞を用いた新規肝細胞モデルの構築とその創薬応用

植山（鳥羽）由希子、水口裕之

YAKUGAKU ZASSHI, 143, 905-909 (2023)

Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism.

Zhou H., Zhiqi X., Morikawa N., Sakurai F., Mizuguchi H., Okuzaki D., Okada N.. Tachibana M.

Biochem. Biophys. Rep., 33, 101416 (2022)

Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus.

Ono R., Nishimae F., Wakida T., Sakurai F., Mizuguchi H.

Sci. Rep., 12, 21560 (2022)

A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine.

Bai, L., Tachibana, K., Murata, M., Inoue, T., Mizuguchi, H., Maeda, S., Ikemura, K., Okuda, M., Kusakabe, T.,?Kondoh, M.

Toxicol Lett., 370, 1-6 (2022)

Decellularized Organ-Derived Scaffold Is a Promising Carrier for Human Induced Pluripotent Stem Cells-Derived Hepatocytes.

Kojima H., Yagi H., Kushige H., Toda Y., Takayama K., Masuda S., Morisaku T., Tsuchida T., Kuroda K., Hirukawa K., Inui J., Nishi K., Nakano Y., Tanaka M., Hori S., Hasegawa Y., Abe Y., Kitago M., Adachi S., Tomi M., Matsuura K., Mizuguchi H., Kitagawa Y.

Cells, 11, 1258 (2022)

Adenovirus vector with ADP gene induces cytopathic effects in HEK293 cells without significant elevation of virus titers.

Shiota A., Nishimae F., Sakurai F., Mizuguchi H.

Anticancer Res., 42, 1719-1727 (2022)

目次に戻る

大阪大学大学院薬学研究科分子生物学分野

Laboratory of Biochemistry and Molecular Biology

Graduate School of Pharmaceutical Sciences, Osaka University

業績｜論文・出版物｜目次｜ALL